https://oskar-bordeaux.fr/handle/20.500.12278/172249 Tue, 07 Apr 2026 11:28:34 GMT 2026-04-07T11:28:34Z https://oskar-bordeaux.fr:443/bitstream/id/c86f35df-7951-43df-8daf-c5c5f0229073/ https://oskar-bordeaux.fr/handle/20.500.12278/172249 https://oskar-bordeaux.fr/handle/20.500.12278/207961 Bulletin BiblioDem 2025-22-5 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants sont analysés :1. Cai Y, Fang L, Yang J, Zhou X, Liu L, Li A, et al. Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease. JAMA Neurol. 2025;82(8):848-58. 2. Chou YC, Han ML, Chiu THT, Lee MS, Chiou JM, Chen JH, et al. Longitudinal Association of Inflammatory Diets on Cognition in Older Adults: Insights from the Oral-Gut-Brain Axis. J Am Geriatr Soc. 2025;73(9):2747-56. 3. Ma'u E, Cullum S, Rohr S, Brayne EC. Are modifiable risk factors for dementia really modifiable? Curr Opin Psychiatry. 2025;38(5):348-54. 4. Mila-Aloma M, Tosun D, Schindler SE, Hausle I, Petersen KK, Li Y, et al. Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks. Ann Neurol. 2025;98(3):508-23. 5. Mitchell JJ, Hamer M, James SN, Norris T, Jefferis BJ, Wannamethee SG, et al. Bidirectional associations of Physical Activity and Cognitive Function in Midlife Adults: A Longitudinal Analysis across 26 years follow-up. Am J Epidemiol. 2025. 6. Paczynski M, Hofmann A, Posey Z, Gregersen M, Rudman M, Ellington D, et al. Lecanemab Treatment in a Specialty Memory Clinic. JAMA Neurol. 2025;82(7):655-65. 7. Pichet Binette A, Smith R, Salvado G, Tideman P, Glans I, van Westen D, et al. Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease. JAMA Neurol. 2025;82(7):666-75. 8. Piura YD, Satyadev N, Corriveau-Lecavalier N, Kuchenbecker LA, Haydu LE, Geschwind MD, et al. Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia. Ann Neurol. 2025;98(4):764-76. 9. Qian Y, Pomeroy ML, Petchler CM, Abshire Saylor M, Cudjoe TKM, Ornstein KA. The Epidemiology of Social Isolation and Loneliness Among Family and Unpaid Caregivers of Older Adults: Findings From the National Study of Caregiving. J Gerontol B Psychol Sci Soc Sci. 2025;80(7). 10. Skillback TB, Jonsson L, Skoog I, Blennow K, Eriksdotter M, Zetterberg H, et al. Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia. JAMA Neurol. 2025;82(6):580-8. 11. Smith JR, Pike JR, Gottesman RF, Knopman DS, Lutsey PL, Palta P, et al. Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia. JAMA Neurol. 2025;82(7):644-54. 12. Walsemann KM, Jackson HM, Boardman JD, Herd P. APOE genotype and cognitive decline: educational context as a moderator of genetic risk. J Gerontol B Psychol Sci Soc Sci. 2025;80(8). Wed, 10 Dec 2025 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/207961 2025-12-10T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207368 Bulletin BiblioDem 2025-22-4 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants sont analysés : 1. Blandi L, Bertuccio P, Signorelli C, Brand H, Clemens T, Renzi C, et al. Herpes zoster as risk factor for dementia: a matched cohort study over 20 years in a 10-million population in Italy. J Prev Alzheimers Dis. 2025:100167. 2. Eyting M, Xie M, Michalik F, Hess S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-46. 3. Imamura K, Kawai H, Ejiri M, Sasai H, Ihara K, Nakada H, et al. Association between the use of information and communication technology and cognitive decline stratified by social isolation: The Otassha study. J Prev Alzheimers Dis. 2025:100138. 4. Moses Appel A, Jensen-Dahm C, Munk Laursen T, Waldemar G, Janbek J. The Effect of Influenza Vaccination on Hospitalization and Mortality Among People With Dementia. J Am Geriatr Soc. 2025;73(5):1498-505. 5. Myran DT, Pugliese M, Harrison LD, Stall NM, Webber C. Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis. JAMA Neurol. 2025;82(6):570-9. 6. Oh HS, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, et al. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's disease. Nat Med. 2025;31(5):1592-603. 7. Pansieri J, Pisa M, Yee S, Gutnikova A, Ridgeon E, Hickman R, et al. Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex. Ann Neurol. 2025(6):1067-73. 8. Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes Zoster Vaccination and Dementia Occurrence. JAMA. 2025;333(23):2083-92. 9. Wang Y, Zang EX, Davis-Plourde K, Vander Wyk B, Gill TM, Becher RD. Incidence of Frailty, Dementia, and Disability Among Community-Living Older Americans According to County-Level Disadvantage. J Am Geriatr Soc. 2025(6):1847-56. 10. Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, et al. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials. JAMA Neurol. 2025;82(5):461-9. Fri, 01 Aug 2025 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/207368 2025-08-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207367 Bulletin BiblioDem 2025-22-3 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Coughlan GT, Klinger HM, Boyle R, Betthauser TJ, Binette AP, Christenson L, et al. Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis. JAMA Neurol. 2025;82(4):364-75. 2. Duggan MR, Paterson C, Lu Y, Biegel H, Dark HE, Cordon J, et al. The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20-year dementia risk. Alzheimers Dement. 2025;21(2):e14549. 3. Gong Y, Chen H, Gu Y, Shen J, Shen T, Ding Y, et al. Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality. J Prev Alzheimers Dis. 2025;12(5):100100. 4. Harrison KL, Morgan BE, Friend J, Garrett SB, Looi D, Halim M, et al. "By the Time We Knew ...": Poetic Analysis of End-of-Life Caregiving Experiences for Rapidly Progressive and Slower-Duration Dementia Syndromes. J Am Geriatr Soc. 2025(5):1406-18. 5. Llibre-Guerra JJ, Fernandez MV, Joseph-Mathurin N, Bian S, Carter K, Li Y, et al. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia. Nat Med. 2025(4):1267-75. 6. Nihart AJ, Garcia MA, El Hayek E, Liu R, Olewine M, Kingston JD, et al. Bioaccumulation of microplastics in decedent human brains. Nat Med. 2025;31(4):1114-9. 7. Octary T, Fajarini M, Arifin H, Chen R, Sung CM, Chang LF, et al. Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials. J Prev Alzheimers Dis. 2025;12(5):100091. 8. Rosen J, Jessen F. Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease. J Prev Alzheimers Dis. 2025;12(4):100102. Sun, 01 Jun 2025 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/207367 2025-06-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207366 Bulletin BiblioDem 2025-22-2 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Cai Y, Fang L, Li A, Yang J, Zhou X, He Z, et al. Educational attainment, Abeta, tau, and structural brain reserve in Alzheimer's disease. Alzheimers Dement. 2025;21(2):e14400. 2. Coley N, Hoevenaar-Blom MP, Shourick J, van Charante EPM, van Dalen JW, van Gool WA, et al. Searching for responders to multidomain dementia prevention in late life: A pooled analysis of individual participant data from the MAPT and preDIVA trials. Alzheimers Dement. 2025;21(2):e14472. 3. Farmer JG, Macchia L, Bu F, Gong J, Steptoe A, Demakakos P, et al. Prosocial Intentions and Subsequent Cognitive Health: A Prospective Cohort Study. J Gerontol B Psychol Sci Soc Sci. 2025;80(3). 4. Karakose S, Luchetti M, Stephan Y, Sutin AR, Terracciano A. Life satisfaction and risk of dementia over 18 years: an analysis of the National Alzheimer's Coordinating Center dataset. Geroscience. 2025;47(1):1319-28. 5. Westphal Filho FL, Moss Lopes PR, Menegaz de Almeida A, Sano VKT, Tamashiro FM, Goncalves OR, et al. Statin use and dementia risk: A systematic review and updated meta-analysis. Alzheimers Dement (N Y). 2025;11(1):e70039. 6. Wiels WA, Oomens JE, Engelborghs S, Baeken C, von Arnim CAF, Boada M, et al. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025;82(3):296-310. 7. Williams ME, Fennema-Notestine C, Bell TR, Lin SJ, Glatt SJ, Kremen WS, et al. Neuroimaging Predictors of Cognitive Resilience against Alzheimer's Disease Pathology. Ann Neurol. 2025;97(6):1038-50. Tue, 01 Apr 2025 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/207366 2025-04-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/207365 Bulletin BiblioDem 2025-22-1 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants sont analysés : 1. Aunsmo RH, Strand BH, Anstey KJ, Bergh S, Kivimaki M, Kohler S, et al. Associations between depression and anxiety in midlife and dementia more than 30 years later: The HUNT Study. Alzheimers Dement (Amst). 2024;16(4):e70036. 2. Benussi A, Huber H, Tan K, Cantoni V, Rivolta J, Cotelli MS, et al. Plasma p-tau(217) and neurofilament/p-tau(217) ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration. Alzheimers Dement. 2025;21(2):e14482. 3. Chen Y, Grodstein F, Capuano AW, Wang T, Bennett DA, James BD. Late-life social activity and subsequent risk of dementia and mild cognitive impairment. Alzheimers Dement. 2025;21(1):e14316. 4. Marseglia A, Dartora C, Samuelsson J, Poulakis K, Mohanty R, Shams S, et al. Biological brain age and resilience in cognitively unimpaired 70-year-old individuals. Alzheimers Dement. 2025;21(2):e14435. 5. Qureshi D, Luben R, Hayat S, Talarico R, Allen NE, Kuzma E, et al. Role of age and exposure duration in the association between metabolic syndrome and risk of incident dementia: a prospective cohort study. Lancet Healthy Longev. 2024;5(12):100652. 6. van Lent DM, Mesa HG, Short MI, Gonzales MM, Aparicio HJ, Salinas J, et al. Association between dietary inflammatory index score and incident dementia. Alzheimers Dement. 2025;21(1):e14390. Sat, 01 Feb 2025 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/207365 2025-02-01T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204663 Bulletin BiblioDem 2024-21-7 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Belloy ME, Le Guen Y, Stewart I, Williams K, Herz J, Sherva R, et al. Role of the X Chromosome in Alzheimer Disease Genetics. JAMA Neurol. 2024;81(10):1032-42. 2. Engels-Domínguez N, Riphagen JM, Van Egroo M, Koops EA, Smegal LF, Becker JA, et al. Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals. Ann Neurol. 2024;96(4):650-61. 3. Lao P, Young CB, Ezeh C, Lacayo B, Seblova D, Andrews RM, et al. Loneliness, cerebrovascular and Alzheimer's disease pathology, and cognition. Alzheimers Dement. 2024;20(10):7113-23. 4. Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, et al. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA. 2024;332(15):1245-57. 5. Sewell KR, Doecke JD, Xiong C, Benzinger T, Masters CL, Laske C, et al. Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease. Alzheimers Dement. 2024;20(11):7923-39. 6. Yu L, Aziz AUR, Zhang X, Li W. Investigating the causal impact of different types of physical activity on psychiatric disorders across life stages: A Mendelian randomization study. J Affect Disord. 2024;365:606-13. Fri, 30 Aug 2024 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/204663 2024-08-30T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204597 Bulletin BiblioDem 2024-21-08 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Balamurali BT, Jer-Ming C. Performance Assessment of ChatGPT versus Bard in Detecting Alzheimer's Dementia. Diagnostics (Basel). 2024;14(8). 2. Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, et al. Unexpected Low Rate of Amyloid-beta Pathology in Multiple Sclerosis Patients. Ann Neurol. 2024;96(3):453-9. 3. Chen Y, Power MC, Grodstein F, Capuano AW, Lange-Maia BS, Moghtaderi A, et al. Correlates of missed or late versus timely diagnosis of dementia in healthcare settings. Alzheimers Dement. 2024;20(8):5551-60. 4. Kang M, Li C, Mahajan A, Spat-Lemus J, Durape S, Chen J, et al. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment. JAMA Psychiatry. 2024;81(10):993-1002. 5. Knopman DS, Pike JR, Gottesman RF, Sharrett AR, Windham BG, Mosley TH, Jr., et al. Patterns of cognitive domain abnormalities enhance discrimination of dementia risk prediction: The ARIC study. Alzheimers Dement. 2024;20(7):4559-71. Wed, 30 Oct 2024 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/204597 2024-10-30T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/204524 Bulletin BiblioDem 2024-21-06 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro les articles suivants ont été analysés : 1. Hu W, Zhang WB, Liu BP, Jia CX. Associations and Mediating Pathways Between Childhood Adversity and Risk of Dementia: A Cohort Study in the UK Biobank. J Gerontol A Biol Sci Med Sci. 2024;79(8). 2. Kazibwe R, Schaich CL, Muhammad AI, Epiu I, Namutebi JH, Chevli PA, et al. Effect of vigorous-intensity physical activity on incident cognitive impairment in high-risk hypertension. Alzheimers Dement. 2024;20(7):4602-12. 3. Mobley AR, Subramanian A, Champsi A, Wang X, Myles P, McGreavy P, et al. Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk. Nat Med. 2024;30(8):2288-94. 4. Neal DP, Kucera M, van Munster BC, Ettema TP, Dijkstra K, Muller M, et al. Cost-effectiveness of the FindMyApps eHealth intervention vs. digital care as usual: results from a randomised controlled trial. Aging Ment Health. 2024;28(11):1457-70. 5. Ramos-Cejudo J, Corrigan JK, Zheng C, Swinnerton KN, Jacobson SR, La J, et al. Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder. Alzheimers Dement. 2024;20(6):4106-14. 6. Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, et al. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. JAMA Neurol. 2024;81(6):582-93. Mon, 08 Jul 2024 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/204524 2024-07-08T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/201065 Bulletin BiblioDem 2024-21-4/5 COMITÉ DE RÉDACTION BIBLIODEM, / Dans de numéro, les articles suivants ont été analysés : 1. Freedman VA, Cornman JC. Dementia Prevalence, Incidence and Mortality Trends Among US Adults Ages 72 and Older, 2011-2021. J Gerontol A Biol Sci Med Sci. 2024. 2. Ghanem A, Berry DS, Burkes A, Grill N, Hall TM, Hart KA, et al. Prevalence of and Annual Conversion Rates to Mild Cognitive Impairment and Dementia: Prospective, Longitudinal Study of an Essential Tremor Cohort. Ann Neurol. 2024;95(6):1193-204. 3. Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, et al. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024;81(6):619-29. 4. Tesi N, van der Lee S, Hulsman M, van Schoor NM, Huisman M, Pijnenburg Y, et al. Cognitively healthy centenarians are genetically protected against Alzheimer's disease. Alzheimers Dement. 2024;20(6):3864-75. 5. Hernández-Ruiz V, Roubaud-Baudron C, Von Campe H, Retuerto N, Mégraud F, Helmer C, et al. Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort. J Am Geriatr Soc. 2024;72(4):1191-8. 6. Saadmaan G, Dalmasso MC, Ramirez A, Hiltunen M, Kemppainen N, Lehtisalo J, et al. Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial. Alzheimers Dement. 2024;20(6):4345-50. Tue, 23 Jul 2024 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/201065 2024-07-23T00:00:00Z https://oskar-bordeaux.fr/handle/20.500.12278/200366 Bulletin BiblioDem 2024-21-2/3 COMITÉ DE RÉDACTION BIBLIODEM, / Dans ce numéro, les articles suivants ont été analysés : 1. Adesuyan M, Jani YH, Alsugeir D, Howard R, Ju C, Wei L, et al. Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study. Neurology. 2024;102(4):e209131. 2. Beck ED, Yoneda T, James BD, Bennett DA, Hassenstab J, Katz MJ, et al. Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis. Alzheimers Dement. 2023. 3. Biesbroek JM, Coenen M, DeCarli C, Fletcher EM, Maillard PM, Barkhof F, et al. Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients. Alzheimers Dement. 2024;20(4):2980-9. 4. Cantuaria ML, Pedersen ER, Waldorff FB, Wermuth L, Pedersen KM, Poulsen AH, et al. Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults. JAMA Otolaryngol Head Neck Surg. 2024;150(2):157-64. 5. Dhana K, Agarwal P, James BD, Leurgans SE, Rajan KB, Aggarwal NT, et al. Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia. JAMA Neurol. 2024;81(3):233-9. 6. Gu Y, Honig LS, Kang MS, Bahl A, Sanchez D, Reyes-Dumeyer D, et al. Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort. Alzheimers Dement. 2024. 7. Hendriks S, Ranson JM, Peetoom K, Lourida I, Tai XY, de Vugt M, et al. Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurol. 2024(2):134-42. 8. Huh J, Arpawong TE, Gruenewald TL, Fisher GG, Prescott CA, Manly JJ, et al. General cognitive ability in high school, attained education, occupational complexity, and dementia risk. Alzheimers Dement. 2024;20(4):2662-9. 9. Phan TX, Baratono S, Drew W, Tetreault AM, Fox MD, Darby RR, et al. Increased Cortical Thickness in Alzheimer's Disease. Ann Neurol. 2024. 10. Shimada H, Doi T, Tsutsumimoto K, Makino K, Harada K, Tomida K, et al. Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation. J Alzheimers Dis. 2024;98(2):659-69. Mon, 10 Jun 2024 00:00:00 GMT https://oskar-bordeaux.fr/handle/20.500.12278/200366 2024-06-10T00:00:00Z